Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven Park, MD
University of North Carolina, Chapel Hill
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Seby B. Jones Cancer Center
Boone, North Carolina, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Northeast Medical Center
Concord, North Carolina, United States
- Moses Cone Regional Cancer Center
Greensboro, North Carolina, United States
- Leo Jenkins Cancer Center, East Carolina University Medical Center
Greenville, North Carolina, United States
- Rex Healthcare
Raleigh, North Carolina, United States
- Marion L. Shepard Cancer Center
Washington, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 31 Dec 2013
- Completion
- 31 Aug 2016
- Last update posted
- 24 May 2017
- Registered enrollment
- 23
- Registry id
- NCT01234467
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.